OHRE Pharma
FranceEntry
2018
Hold
3yr
Exit
2021
Who owns OHRE Pharma?
OHRE Pharma was owned by VATEL CAPITAL through Vatel Capital (2018 vintage) from 2018 to 2021, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021
More from Vatel Capital
Other portfolio companies in the same fund.
More VATEL CAPITAL portfolio companies
From the same investor, across funds.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
US
Track OHRE Pharma
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy OHRE Pharma?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on OHRE Pharma.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue